ADAPTIMMUNE THERAPEUTICS PLC Available-for-sale Securities, Gross Realized Losses
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Available-for-sale Securities, Gross Realized Losses of $646.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses · last filed 2018-03-15
- ADAPTIMMUNE THERAPEUTICS PLC available-for-sale securities, gross realized losses for fiscal 2017 was $646.00K.
| Period end | Available-for-sale Securities, Gross Realized Losses 12 month |
|---|---|
| 2017-12-31 | $646.00K 10-K · filed 2018-03-15 |